-- The Tinnitus (Ear Nose Throat Disorders) pipeline guide reviews of key players involved in therapeutic development for Tinnitus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 1, 2 and 8 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 2 and 1 molecules, respectively.
Tinnitus (Ear Nose Throat Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Key Players:
AudioCure Pharma GmbH
Auris Medical Holding AG
Knopp Biosciences LLC
Merz Pharma GmbH & Co KgaA
Otonomy Inc
SciFluor Life Sciences LLC
Sound Pharmaceuticals Inc
Get Sample Copy of Report@ http://www.reportsweb.com/inquiry&RW0001767500/sample
Tinnitus is a condition characterized by ringing, swishing, or other noises that originating in the ear or head. Causes of tinnitus are age-related hearing loss, exposure to loud noises, earwax blockage in the ear canal, smoking and abnormal bone growth in the ear. Symptoms include ringing; buzzing, roaring, clicking, whistling, hissing, or squealing, noises may appear low or high in pitch.
Publisher's Pharmaceutical and Healthcare latest pipeline guide Tinnitus - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Tinnitus (Ear Nose Throat Disorders) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
- The pipeline guide provides a snapshot of the global therapeutic landscape of Tinnitus (Ear Nose Throat Disorders) .
- The pipeline guide reviews pipeline therapeutics for Tinnitus (Ear Nose Throat Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Tinnitus (Ear Nose Throat Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Tinnitus (Ear Nose Throat Disorders) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Tinnitus (Ear Nose Throat Disorders)
Buy This Report@ http://www.reportsweb.com/buy&RW0001767500/buy/2000
List of Tables:
Number of Products under Development for Tinnitus, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Tinnitus - Pipeline by AudioCure Pharma GmbH, H1 2017
Tinnitus - Pipeline by Auris Medical Holding AG, H1 2017
Tinnitus - Pipeline by Knopp Biosciences LLC, H1 2017
Tinnitus - Pipeline by Merz Pharma GmbH & Co KgaA, H1 2017
Tinnitus - Pipeline by Otonomy Inc, H1 2017
Tinnitus - Pipeline by SciFluor Life Sciences LLC, H1 2017
Tinnitus - Pipeline by Sound Pharmaceuticals Inc, H1 2017
Tinnitus - Dormant Projects, H1 2017
Inquiry for This Report@ http://www.reportsweb.com/inquiry&RW0001767500/buying
List of Figures:
Number of Products under Development for Tinnitus, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Routes of Administration, H1 2017
Number of Products by Stage and Molecule Types, H1 2017
Contact Info:
Name: Sameer Joshi
Email: Send Email
Organization: ReportsWeb
Phone: +91-20-67278686
Website: http://www.reportsweb.com/tinnitus-pipeline-review-h1-2017
Release ID: 263678
Google
RSS